|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.479 EUR | +0.46% |
|
-2.63% | -33.11% |
| 12:05pm | Sandoz Concludes Purchase of Evotec's Biologics Platform | MT |
| 11:38am | Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership | RE |
Evolution of the Average Target: Evotec SE
Evolution of the Target Price: Evotec SE
Changes in Analyst Recommendations: Evotec SE
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +55.92% | |||||
| +25.03% | |||||
| +10.69% | |||||
| +24.35% | |||||
| +21.91% | |||||
| -1.74% | |||||
| +1.9% | |||||
| +10.93% | |||||
| +19.25% | |||||
| +4.64% | |||||
| Average | +17.29% | |||||
| Weighted average by Cap. | +16.26% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| RBC | Charles Weston |
| DEUTSCHE BANK RESEARCH | Fynn Scherzler |
| WARBURG RESEARCH | Christian Ehmann |
| JEFFERIES | Benjamin Jackson |
| MORGAN STANLEY | Thibault Boutherin |
| BERENBERG | Gerhard Orgonas |
| DEUTSCHE BANK | Falko Friedrichs |
| BAADER BANK | Bruno Bulic |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EVT Stock
- Consensus Evotec SE
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition